New way of viewing cells could lead to easier routes for drug manufacture

December 10, 2008,

Research by a Michigan State University chemist could eventually lead to a quicker and easier way of developing protein-based drugs that are key to treating a number of diseases, including cancer, diabetes and hepatitis.

Proteins used in drug manufacture and research often are made within genetically modified Escherichia coli, a one-cell bacteria. That protein tends to collect into what scientists call inclusion bodies. Those hard-to-separate clumps render up to 95 percent of the protein unusable, according to associate chemistry professor David P. Weliky.

Some can be recovered by breaking down the protein to separate it, but because protein structure determines its function, another step must be added to "refold" it into its original configuration.

Weliky and colleagues took a closer look at the structure of the proteins that make up these inclusion bodies. Learning what makes them stick together might yield some clues as to how to separate them, he said, and that could make the manufacturing process more efficient.

Instead of employing more commonly used infrared spectroscopy to look at dehydrated samples, the researchers used nuclear magnetic resonance spectroscopy using whole cells. That technology analyzes the magnetic properties of an atom's nucleus.

While best known as medical diagnostic imaging technology, Weliky and colleagues view NMR as a powerful approach to analyzing biological molecules, including bacterial inclusion bodies. Because the inclusion body protein appeared to be predominantly folded rather than unfolded, it might be possible to extract protein without separating and then refolding, Weliky said.

"This study highlights our ability to probe the molecular structure of a single protein in whole cells and to apply advanced analytical and biochemical methods to a problem of general significance in biotechnology," Weliky said.

Source: Michigan State University

Explore further: Bacterial and host cell proteins interact to regulate Chlamydia's 'exit strategy'

Related Stories

Research reveals atomic-level changes in ALS-linked protein

January 18, 2018

For the first time, researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases ...

Study uncovers secrets of a clump-dissolving protein

January 22, 2015

Workhorse molecules called heat-shock proteins contribute to refolding proteins that were once misfolded and clumped, causing such disorders as Parkinson's disease, amyotrophic lateral sclerosis, and Alzheimer's disease. ...

Freeing protein-based drugs from bacteria's natural traps

October 13, 2008

In a finding that could speed the development of new protein-based drugs for fighting diabetes, hepatitis, and other diseases, researchers are reporting progress toward preventing or destroying an unusual structure that reduces ...

Recommended for you

Arctic wintertime sea ice extent is among lowest on record

March 23, 2018

Sea ice in the Arctic grew to its annual maximum extent last week, and joined 2015, 2016 and 2017 as the four lowest maximum extents on record, according to scientists at the NASA-supported National Snow and Ice Data Center ...

Genome of American cockroach sequenced for the first time

March 23, 2018

A team of researchers with South China Normal University and the Chinese Academy of Sciences has for the first time sequenced the genome of the American cockroach. In their paper published in the journal Nature Communications, ...

New innovations in cell-free biotechnology

March 23, 2018

A Northwestern University-led team has developed a new way to manufacture proteins outside of a cell that could have important implications in therapeutics and biomaterials.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.